Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
State Key Laboratory of Oncology in South China · Sun Yat-sen University Cancer Center · +25 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
525
total citations
- FWCI
- 28.91
- Percentile
- 100%
- References
- 33
Citations per year
Authors
28- LZLi ZhangCorresponding
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Sun Yat-sen University
- YHYan Huang
Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
- SHShaodong Hong
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Sun Yat-sen University
- YYYunpeng Yang
Sun Yat-sen University Cancer Center, Sun Yat-sen University, State Key Laboratory of Oncology in South China
- GYGengsheng Yu
Jiangmen Central Hospital
Topics & keywords
Topics
Keywords
- Medicine
- Gemcitabine
- Fluorouracil
- Nasopharyngeal carcinoma
- Internal medicine
- Cisplatin
- Clinical endpoint
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.